Explore more publications!
Science Times Observer
Got News to Share?

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 8, 2026

New Molecular Switch that Boosts Tooth Regeneration Discovered
Mar. 8, 2026

New Molecular Switch that Boosts Tooth Regeneration Discovered

Indeterminate EIN Presswire
Alternative to Meds Center Highlights Long-Term Fanapt Risks and Individualized Antipsychotic Tapering Support
Mar. 8, 2026

Alternative to Meds Center Highlights Long-Term Fanapt Risks and Individualized Antipsychotic Tapering Support

Indeterminate EIN Presswire
Alternative to Meds Center Highlights Prozac Risks, SSRI Controversy, & Safer Paths for Fluoxetine Tapering and Recovery
Mar. 8, 2026

Alternative to Meds Center Highlights Prozac Risks, SSRI Controversy, & Safer Paths for Fluoxetine Tapering and Recovery

Indeterminate EIN Presswire
Alternative to Meds Center Raises Awareness on Zoloft Side Effects, SSRI Withdrawal Risks, and Holistic Recovery Options
Mar. 8, 2026

Alternative to Meds Center Raises Awareness on Zoloft Side Effects, SSRI Withdrawal Risks, and Holistic Recovery Options

Indeterminate EIN Presswire
Alternative to Meds Center Highlights Clinical Approach to Safe Zoloft Tapering and SSRI Withdrawal Support
Mar. 8, 2026

Alternative to Meds Center Highlights Clinical Approach to Safe Zoloft Tapering and SSRI Withdrawal Support

Indeterminate EIN Presswire
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
Mar. 8, 2026

Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)

Indeterminate GlobeNewswire
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
Mar. 8, 2026

Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)

Indeterminate GlobeNewswire
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Mar. 8, 2026

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Indeterminate GlobeNewswire
Emergenetics Leadership and Team Development Programs Help Organizations Strengthen and Improve Team Performance, Communication and Collaboration
Mar. 8, 2026

Emergenetics Leadership and Team Development Programs Help Organizations Strengthen and Improve Team Performance, Communication and Collaboration

Indeterminate GlobeNewswire
Memopezil 2026 Consumer Report: How the 'Natural Donepezil' Mechanism Supports Acetylcholine for Brain Health
Mar. 8, 2026

Memopezil 2026 Consumer Report: How the 'Natural Donepezil' Mechanism Supports Acetylcholine for Brain Health

Indeterminate GlobeNewswire
No Deposit Bonus Canada 2026 Free Spins No Deposit by Cafe Casino
Mar. 8, 2026

No Deposit Bonus Canada 2026 Free Spins No Deposit by Cafe Casino

Indeterminate GlobeNewswire
Catching Fake Insurance Claims: Why Image Verification Has Become Essential
Mar. 8, 2026

Catching Fake Insurance Claims: Why Image Verification Has Become Essential

Indeterminate GlobeNewswire
Shangyuan Display Redefines Jewelry Showcase Manufacturing with Landmark Success at INHORGENTA 2026
Mar. 8, 2026

Shangyuan Display Redefines Jewelry Showcase Manufacturing with Landmark Success at INHORGENTA 2026

Indeterminate GlobeNewswire
CAPHRA Says Nicotine Should Not Be Criminalised Over Illicit Vape Products
Mar. 8, 2026

CAPHRA Says Nicotine Should Not Be Criminalised Over Illicit Vape Products

Indeterminate GlobeNewswire
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
Mar. 8, 2026

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

Indeterminate GlobeNewswire
Trevor Vick Publishes Persistent Infrastructure Identity (PIID) Framework, Establishing a New Digital Identity Layer for the Built Environment
Mar. 8, 2026

Trevor Vick Publishes Persistent Infrastructure Identity (PIID) Framework, Establishing a New Digital Identity Layer for the Built Environment

Indeterminate GlobeNewswire
Symphony Therapeutics to Present NanoM-Wafer™ Artificial Tear Film Ocular Insert
Mar. 8, 2026

Symphony Therapeutics to Present NanoM-Wafer™ Artificial Tear Film Ocular Insert

Indeterminate EIN Presswire
Symphony Therapeutics to Present on OcuHeal-UV400+, a UV-Protective LNP Eyedrop
Mar. 8, 2026

Symphony Therapeutics to Present on OcuHeal-UV400+, a UV-Protective LNP Eyedrop

Indeterminate EIN Presswire
H2Ocean Highlights Sea Salt Innovations at 4th ICCHD & 9th Annual UTRGV School of Medicine Research Symposium
Mar. 8, 2026

H2Ocean Highlights Sea Salt Innovations at 4th ICCHD & 9th Annual UTRGV School of Medicine Research Symposium

Indeterminate EIN Presswire
SolaDrive Expands Windows VPS Hosting Services for Businesses Running Windows-Based Applications
Mar. 8, 2026

SolaDrive Expands Windows VPS Hosting Services for Businesses Running Windows-Based Applications

Indeterminate EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions